Leukodystrophy, Globoid Cell: Clinical Trials

2 trials for Leukodystrophy, Globoid Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1
Phase 21Completed 1

Follow Leukodystrophy, Globoid Cell: new trials by email Literature Review of Leukodystrophy, Globoid Cell trials Research Report on Leukodystrophy, Globoid Cell

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
ALD-101 - Inherited Metabolic Diseases, Lysosomal Storage Disorders
Phase 3TerminatedAldagen402008-03-012014-07-08
Stem Cell Transplant for Inborn Errors of Metabolism
Stem Cell Transplant, Busulfan, Cyclophosphamide, Antithymocyte Globulin - Adrenoleukodystrophy, Metachromatic Leukodystrophy
Phase 2 / Phase 3CompletedMasonic Cancer Center, University of Minnesota1351995-01-012017-12-28

Narrower conditions

Adrenoleukodystrophy (2)  ·  Fucosidosis (2)  ·  Gangliosidosis, GM1 (2)  ·  Leukodystrophy, Metachromatic (2)  ·  Sandhoff Disease (2)  ·  Tay-Sachs Disease (2)  ·  Canavan Disease (1)  ·  Gaucher Disease (1)  ·  Lysosomal Storage Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucolipidoses (1)  ·  Mucopolysaccharidoses (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis II (1)

Broader conditions

Adrenal Gland Diseases (2)  ·  Adrenal Insufficiency (2)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Central Nervous System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Demyelinating Diseases (2)  ·  Endocrine System Diseases (2)  ·  Gangliosidoses (2)  ·  Gangliosidoses, GM2 (2)  ·  Genetic Diseases, Inborn (2)  ·  Genetic Diseases, X-Linked (2)  ·  Hereditary Central Nervous System Demyelinating Diseases (2)

Interventions

Antilymphocyte Serum (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Stem Cell Transplantation (1)

Sponsors

Aldagen (1)  ·  Masonic Cancer Center, University of Minnesota (1)

Countries

United States (2)

Top investigators

James Hinson, MD (1)  ·  Joanne Kurtzberg, MD (1)  ·  Paul Orchard, MD (1)

Results publications

PMID 21586746